Healthcare provider, LivingCare Group has been selected as the proposed imaging partner for the IMProVE clinical trial, a prostate cancer early-detection programme funded by Yorkshire Cancer Research.
Scans that make prostate cancer cells glow can eliminate the need for invasive biopsies and cut false positive—and they're ...
We’re prostate cancer experts. Here are the benefits of quick and targeted MRI scans - Urologists, radiologists and pathologists from Europe and the US agreed an “expert consensus statement” on prosta ...
Patients in Leicestershire and Rutland now have access to a new state-of-the-art MRI scanner at the Leicester General Hospital.
Full-body MRIs are all the rage. We take a look at three major companies offering such testing.
SIGNA Sprint with Freelium, a new 1.5T sealed magnet MRI system, combines a sustainable design with uncompromised image quality, and operational autonomy to expand access to advanced MR, even in ...
A combined PSMA-PET/MRI scanner better detected clinically significant prostate cancer in men on active surveillance. The addition of piflufolastat F18 (18 F-DCFPyL) prostate-specific membrane antigen ...
In a cohort of US veterans with prostate cancer who were on active surveillance, negative multiparametric MRI had a 75% negative predictive value for ruling out disease of grade group 2 or higher at ...
In a retrospective study of 200 biopsy-naïve men, we compared transperineal in-bore MRI-guided biopsies with transrectal MRI-ultrasound fusion biopsies for detecting clinically significant prostate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results